Vaginal mesh manufacturer CR Bard Inc. has been ordered to pay damages of $5.5 million to a woman who was harmed by transvaginal mesh used to treat stress urinary incontinence.
A jury found Bard negligent in its handling of the device, and concluded that the woman deserved the award because of the complications she has suffered since having the implant fitted. Christine Scott from Bakersfield was left incontinent, in severe pain and unable to have sexual relations with her husband. She has had multiple surgeries to treat the complications from the Avaulta Plus mesh device.
This was the first case to go to trial – there are hundreds of others awaiting trial. The lawsuits are claiming that implants made by a number of manufacturers have caused harm and organ damage. The defendants (the mesh makers) in these pending trials have been keeping a close eye on the case: the results of the first few cases are important markers of how things will go in future trials. There is speculation as to how the manufacturers will react if they lose a number of cases.
Bard withdrew the Avaulta Plus product from the US market on 1st July but continues to sell it outside the US. Bard officials are claiming that the complications are not the fault of the company’s actions and have said they will appeal.
Please feel free to leave a comment on this news.